Corteva, Inc. $CTVA Stock Purchased by Danske Bank A S

Danske Bank A S increased its position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 9.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 909,654 shares of the company’s stock after purchasing an additional 75,039 shares during the period. Danske Bank A S’s holdings in Corteva were worth $70,635,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. EFG International AG bought a new position in Corteva during the 2nd quarter valued at $25,000. Compass Financial Management LLC acquired a new position in shares of Corteva during the 2nd quarter valued at $25,000. Elevation Wealth Partners LLC increased its position in shares of Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after purchasing an additional 261 shares during the period. Clearstead Trust LLC bought a new stake in shares of Corteva in the 2nd quarter worth $31,000. Finally, N.E.W. Advisory Services LLC bought a new stake in shares of Corteva in the 2nd quarter worth $33,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently weighed in on CTVA shares. Bank of America upped their price objective on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Weiss Ratings cut Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. JPMorgan Chase & Co. lowered their target price on Corteva from $19.00 to $16.00 and set an “overweight” rating on the stock in a report on Friday. Deutsche Bank reiterated a “buy” rating and issued a $101.00 price target on shares of Corteva in a research report on Monday, August 3rd. Finally, Mizuho set a $16.00 price target on shares of Corteva in a report on Thursday. Fifteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $52.60.

Read Our Latest Analysis on Corteva

Corteva Trading Down 0.2%

Shares of NYSE:CTVA opened at $9.41 on Monday. The stock has a market capitalization of $6.28 billion, a price-to-earnings ratio of 4.96, a PEG ratio of 1.25 and a beta of 0.58. Corteva, Inc. has a 1-year low of $9.01 and a 1-year high of $90.97. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.08 and a current ratio of 1.56. The company has a 50 day moving average price of $37.22 and a 200 day moving average price of $69.57.

Corteva Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be issued a $0.05 dividend. This is a decrease from Corteva’s previous quarterly dividend of $0.18. This represents a $0.20 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Tuesday, December 1st. Corteva’s dividend payout ratio is currently 37.89%.

Key Corteva News

These are some of the CTVA news items that stood out recently:

  • Positive Sentiment: Corteva pointed to new products and cost-cutting efforts as supports for a potential recovery, though these measures have not offset near-term weakness. Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut
  • Neutral Sentiment: Several analysts lowered price targets following the outlook reset. Citigroup and UBS kept neutral ratings, while JPMorgan maintained overweight and RBC kept outperform ratings, signaling some analysts still see potential upside from recent levels. Read More. · Read More. · Read More. · Read More.
  • Negative Sentiment: The earnings miss and lowered full-year outlook are the key near-term headwinds, with Brazil weakness and competitive pricing hurting results. Reuters report on Brazil weakness and forecast cut

Corteva Company Profile

(Free Report)

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.

See Also

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.